TrialFrontiers in pharmacology2026

Low-dose naltrexone as an adjunctive treatment for major depressive disorder: findings from a randomized, double-blind, placebo-controlled hybrid parallel-arm study.

Ben D Moloney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.